Knowing who will not respond to certain drugs will allow us to tailor treatment for maximum benefit and the least side effects.

The drug seemed to be effective even in patients who had failed treatment from other immunosuppressive drugs.

People should be closely monitored, but not because these drugs are especially risky. The real problem in the treatment of depression is that people start medicine and the medicine has side effects or the medicine doesn't work right away, and they get discouraged and they drop out.

[Mothers] ultimately sought treatment because of their own desire to stop using drugs and for reasons related to personal well-being. Those were the only factors we tested; however, there are undoubtedly other reasons, too.

This study, when it is all finally published, will give us a very good idea of how to treat treatment-resistant depression, and what the next step is after the serotonin reuptake inhibitor fails.

This study, when it is all finally published, will give us a very good idea of how to treat treatment-resistant depression, and what the next step is after the SSRI fails.